Literature DB >> 11248139

Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters.

M L O'Brien1, T P Twaroski, M L Cunningham, H P Glauert, B T Spear.   

Abstract

Peroxisome proliferators (PPs) cause hepatomegaly, peroxisome proliferation, and hepatocarcinogenesis in rats and mice, whereas hamsters are less responsive to PPs. PPs increase the activities of enzymes involved in peroxisomal beta-oxidation and omega-hydroxylation of fatty acids, which has been hypothesized to result in oxidative stress. The hypothesis of this study was that differential modulation of antioxidant enzymes and vitamins might account for differences in species susceptibility to PPs. Accordingly, we measured the activities of DT-diaphorase and superoxide dismutase (SOD) and the hepatic content of ascorbic acid and alpha-tocopherol in male Sprague-Dawley rats and Syrian hamsters fed 2 doses of 3 known peroxisome proliferators (dibutyl phthalate [DBP], gemfibrozil, and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) for 6, 34, or 90 days. In untreated animals, the activity of DT-diaphorase was much higher in hamsters than in rats, but the control levels of SOD, ascorbic acid and alpha-tocopherol were similar. In rats and hamsters treated with Wy-14,643, we observed decreases in alpha-tocopherol content and total SOD activity. DT-diaphorase was decreased in activity following Wy-14,643 treatment in rats at all time points and doses, but only sporadically affected in hamsters. Rats and hamsters treated with DBP demonstrated increased SOD activity at 6 days; however, in the rat, DBP decreased SOD activity at 90 days and alpha-tocopherol content was decreased throughout. In gemfibrozil treated rats and hamsters, a decrease in alpha-tocopherol content and an increase in DT-diaphorase activity were observed. In either species, no consistent trend was observed in total ascorbic acid content after treatment with any of the PPs. In conclusion, these data suggest that both rats and hamsters are compromised in antioxidant capabilities following PP treatment and additional hypotheses for species susceptibility should be considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248139     DOI: 10.1093/toxsci/60.2.271

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  11 in total

Review 1.  Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

Authors:  Jeffrey M Peters; Connie Cheung; Frank J Gonzalez
Journal:  J Mol Med (Berl)       Date:  2005-06-23       Impact factor: 4.599

2.  Effects of rosiglitazone treatment on the pentose phosphate pathway and glutathione-dependent enzymes in liver and kidney of rats fed a high-fat diet.

Authors:  Esen Akbay; Nuriye Nuray Ulusu; Füsun Töröner; Göksun Ayvaz; Ferit Taneri; Müjde Aktürk; Metin Arslan; Cimen Karasu
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

3.  Dietary clofibrate stimulates the formation and size of estradiol-induced breast tumors in female August-Copenhagen Irish (ACI) rats.

Authors:  Sonia Mesia-Vela; Rosa I Sanchez; Kathleen G Roberts; Kenneth R Reuhl; Allan H Conney; Frederick C Kauffman
Journal:  Toxicology       Date:  2008-01-06       Impact factor: 4.221

Review 4.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

5.  The effects of di(2-ethylhexyl)phthalate on rat liver in relation to selenium status.

Authors:  Pınar Erkekoglu; Naciye D Zeybek; Belma K Giray; Walid Rachidi; Murat Kızılgün; Isabelle Hininger-Favier; Alain Favier; Esin Asan; Filiz Hincal
Journal:  Int J Exp Pathol       Date:  2013-11-04       Impact factor: 1.925

6.  Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

Authors:  Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
Journal:  PPAR Res       Date:  2010-10-04       Impact factor: 4.964

Review 7.  Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.

Authors:  Nagalakshmi Keshava; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

8.  Clofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents.

Authors:  Sebastian Luci; Beatrice Giemsa; Gerd Hause; Holger Kluge; Klaus Eder
Journal:  BMC Pharmacol       Date:  2007-04-16

9.  Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

Authors:  Roberto Scatena; Patrizia Bottoni; Bruno Giardina
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

10.  The Role of NF-kappaB in PPARalpha-Mediated Hepatocarcinogenesis.

Authors:  Howard P Glauert; Karen Calfee-Mason; Yixin Li; Vani Nilakantan; Michelle L Twaroski; Job Tharappel; Brett T Spear
Journal:  PPAR Res       Date:  2009-01-29       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.